Goldman Sachs
CYTO icon

Goldman Sachs’s Altamira Therapeutics Ltd CYTO Stock Holding History

Goldman Sachs’s Portfolio CYTO Stock Details CYTO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Hold
0
– -$25K – 7068
2016
Q4 		– Hold
0
– – – 6591
2016
Q2 		– Hold
0
– -$90K – 7311
2016
Q1 		– Hold
0
– – – 6116
2015
Q4 		– Hold
0
– -$60K – 7399
2015
Q3 		– Hold
0
– – – 6725
2015
Q2 		– Hold
0
– – – 6651
2015
Q1 		– Hold
0
– – – 6457
2014
Q4 		– Hold
0
– – – 6724
2014
Q3 		– Hold
0
– – – 6566

Other funds holding CYTO

Sofinnova Management VIII
Sofinnova Management VIII Menlo Park, California $183M AUM 4.18% 1-Year Est. Return
Bellevue Group
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
UBS O'Connor
UBS O'Connor Chicago, Illinois $3.76B AUM 62.41% 1-Year Est. Return
Tekla Capital Management
Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return
Perceptive Advisors
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $9.02M AUM 74.48% 1-Year Est. Return
Wasatch Advisors
Wasatch Advisors Salt Lake City, Utah $13.5B AUM 16.58% 1-Year Est. Return
Wedbush Securities
Wedbush Securities Los Angeles, California $3.95B AUM 25.45% 1-Year Est. Return
Sigma Planning Corp
Sigma Planning Corp Ann Arbor, Michigan $3.88B AUM 23.38% 1-Year Est. Return